Background: In the United States, diphtheria-tetanus-acellular pertussis (DTaP) and
inactivated poliovirus (IPV) booster vaccinations are recommended for children 4–6 years of …

The American Academy of Pediatrics currently recommends administering full-dose
diphtheria, tetanus, pertussis,(DTP) vaccine to preterm infants, beginning at 2 months' …

Background: Despite good acellular pertussis vaccine safety and protective efficacy, as well
as high vaccination rates among young children, the incidence of pertussis in the United …

OBJECTIVE: In 2010, California experienced the highest number of pertussis cases in> 60
years, with> 9000 cases, 809 hospitalizations, and 10 deaths. This report provides a …

This report compiles and summarizes all recommendations from CDC's Advisory Committee
on Immunization Practices (ACIP) regarding prevention and control of tetanus, diphtheria …

The decision to replace effective whole-cell vaccines for pertussis with less reactogenic but
potentially less efficacious acellular vaccines for the primary immunization of children in the …

OBJECTIVE. Tetanus, diphtheria, and acellular pertussis vaccination is recommended for
adults who are in contact with infants who are younger than 12 months and in the NICU. The …

ContextIncreasing reports of pertussis among US adolescents, adults, and their infant
contacts have stimulated vaccine development for older age groups. ObjectiveTo assess the …

Background. Despite the dramatic pertussis decrease since the licensure of whole-cell
pertussis (diphtheria-tetanus toxoids-pertussis [DTP]) vaccines in the middle 1940s …

Acellular pertussis vaccines combined with diphtheria and tetanus toxoids have proven to
be well tolerated, immunogenic and effective in reducing pertussis disease in adolescents …